<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02545647</url>
  </required_header>
  <id_info>
    <org_study_id>2015-0624</org_study_id>
    <nct_id>NCT02545647</nct_id>
  </id_info>
  <brief_title>Banded Versus Non-banded Roux-en-y Gastric Bypass</brief_title>
  <acronym>Bandolera</acronym>
  <official_title>Banded Versus Non-banded Roux-en-y Gastric Bypass, a Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rijnstate Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rijnstate Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A Roux-en-Y Gastric Bypass (RYGB) is on the long term not always successful in every patient&#xD;
      because weight regain can occur. An intervention to prevent weight regain in the future is to&#xD;
      place a silicone band (non-adjustable) around the pouch of the RYGB (Banded-RYGB: BRYGB)&#xD;
      which increases weight loss and decreases weight regain on the longer term. The question is&#xD;
      whether primary application of a banded bypass gives a greater weight loss and / or prevent&#xD;
      weight regain in the future versus a standard RYGB.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A Roux-en-Y Gastric Bypass (RYGB) is on the long term not always successful in every patient&#xD;
      because weight regain can occur. An intervention to prevent weight regain in the future is to&#xD;
      place a silicone band (non-adjustable) around the pouch of the RYGB (Banded-RYGB: BRYGB)&#xD;
      which increases weight loss and decreases weight regain on the longer term. The question is&#xD;
      whether primary application of a banded bypass gives a greater weight loss and / or prevent&#xD;
      weight regain in the future versus a standard RYGB.&#xD;
&#xD;
      The Study design is a prospective, randomized, single center study.&#xD;
&#xD;
      Study population: patients who qualify for a RYGB are eligible to participate. The primary&#xD;
      RYGB patients may participate if there is a BMI of 35 kg / m2 with a morbidly obesity-related&#xD;
      comorbidity or a BMI of 40kg / m2 or higher.&#xD;
&#xD;
      Intervention: The standard RYGB with a vertical pouch over a 40 french feeding tube with a&#xD;
      volume of 30-50 ml, is compared with a banded-RYGB (BRYGB)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">September 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage total body weight loss (%TBWL)</measure>
    <time_frame>3 years</time_frame>
    <description>weight loss is measured in kilogram.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage excess weight loss (%EWL)</measure>
    <time_frame>3 years</time_frame>
    <description>excess weight loss is measured in kilogram.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>percentage total body weight regain (%TBWR)</measure>
    <time_frame>3 years</time_frame>
    <description>Weight regain is measured in kilogram.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Decrease in type 2 diabetes mellitus</measure>
    <time_frame>3 years</time_frame>
    <description>measuring glycated hemoglobin, decrease in diabetic medication</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>3 years</time_frame>
    <description>measuring BAROS score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Decrease in dyslipidaemia</measure>
    <time_frame>3 years</time_frame>
    <description>decrease in medication for hypercholesterolaemie. Measuring cholesterol spectrum.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Decrease in hypertension</measure>
    <time_frame>3 years</time_frame>
    <description>Measuring blood pressure</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">130</enrollment>
  <condition>Morbid Obesity</condition>
  <arm_group>
    <arm_group_label>Standard RYGB</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>65 patients undergo a standard Roux-en-Y gastric bypass</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Banded RYGB</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>65 patients undergo a banded RYGB (BRYGB)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BRYGB</intervention_name>
    <description>65 patients undergo a banded RYGB</description>
    <arm_group_label>Banded RYGB</arm_group_label>
    <other_name>banded RYGB</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  all patients who are eligible for a primary RYGB&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Bariatric surgery in history&#xD;
&#xD;
          -  Patients with a language barrier which may affect the compliance with medical advice&#xD;
&#xD;
          -  Any kind of genetic disorders which can be of influence on the monitoring of medical&#xD;
             advice&#xD;
&#xD;
          -  Patients with a disease not related to morbid obesity, such as Cushing or drug&#xD;
             related.&#xD;
&#xD;
          -  Chronic bowel disease for example Crohn's disease or colitis Colitis.&#xD;
&#xD;
          -  Renal impairment (MDRD &lt;30) or hepatic dysfunction (liver function twice the normal&#xD;
             values)&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Patients with treatment-resistant reflux symptoms. Defined as reflux persistent&#xD;
             symptoms despite the use of a minimum dose of proton-pump inhibitors&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rijnstate Hospital</name>
      <address>
        <city>Arnhem</city>
        <zip>6800WC</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <study_first_submitted>September 3, 2015</study_first_submitted>
  <study_first_submitted_qc>September 7, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 10, 2015</study_first_posted>
  <last_update_submitted>June 30, 2016</last_update_submitted>
  <last_update_submitted_qc>June 30, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity, Morbid</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

